Skip to content

EFFECT OF ADVANCED BLOOD PRODUCTS IN THE TREATMENT OF DENTAL IMPLANTS PLACED IN FRONT TEETH REGION

EFFECT OF ADVANCED PLATELET RICH FIBRIN PLUS ON SOFT TISSUE AND HARD TISSUE AROUND DENTAL IMPLANTS PLACED IN ESTHETIC ZONE : A RANDOMISED CLINICAL TRIAL - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/088208
Enrollment
26
Registered
2025-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Interventions

Intervention1: Implants placed with Advanced platelet rich fibrin plus (APRF+) in test site: After clinical and radiographic examination of edentulous site,implant of appropriate size placed using 2 s

Sponsors

Gembali Rawalika
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Good oral hygiene and suitability for implant rehabilitation in two stage procedure. 2.Sufficient bone height and width to receive the implant . 3.Maxillary and mandibular edentulous area from premolar to premolar. 4.Stable occlusal relationship. 5.Healed extraction sockets with the history of extraction minimum six months ago. 6.Systemically healthy patient. 7.Dimensions of implants will be selected depending on CBCT measurement. 8.Patients willing to and fully capable of complying with the study protocol.

Exclusion criteria

Exclusion criteria: 1.Patients who are not cooperating and with systemic co-morbidities which are likely to affect the study outcome (Uncontrolled diabetes mellitus, immunocompromised patients, Psychological problems ,Radiotherapy to head and neck region within past 24 months). 2.Severe periodontal problems. 3.Chronic alcoholism, smoking. 4.When bone or soft tissue regeneration was needed to enhance implant stability or esthetics. 5.Soft and hard tissue defects that can impair the aesthetic outcome of the treated site. 6.Patients under medication which are likely to affect the treatment outcome. 7.Presence of any parafunctional habits. 8.Pregnant or lactating females.

Design outcomes

Primary

MeasureTime frame
The outcome variable of the study will be change in pink esthetic score/white esthetic score, radiographic mean crestal bone change using CBCT from baseline and 6 months with and without use of APRF+. Timepoint: Baseline and 6 months

Secondary

MeasureTime frame
Probing depth, Gingival index and Plaque index ,probing pocket depth ,width of keratinised tissue and thickness of keratinised tissue at baseline and 6 months. Timepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactGembali Rawlika

S.C.B DENTAL COLLEGE AND HOSPITAL,CUTTACK

drsubash007@gmail.com9437008298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026